Tran Phuong Thao

Dr. Tran Phuong Thao

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 May 2025 in The Cleft Palate Craniofacial Journal
Verified
Journal Article
Closed access
THToko Hayakawa
Toko Hayakawa
TTTran Phuong Thao
Tran Phuong Thao
TNTeruyuki Niimi
Teruyuki Niimi
HIHideto Imura
Hideto Imura
HFHiroo Furukawa
Hiroo Furukawa
LALe Kha Anh
Le Kha Anh
This report highlights the long-term management of velopharyngeal insufficiency (VPI) and misarticulation in an 18-year-old male with unilateral cleft lip and palate. Despite primary and secondary surgeries, persistent VPI required a speech appliance and intensive therapy to address glottal stops and pharyngeal fricatives. While therapy eliminated these errors, residual VPI continued to impact speech intelligibility. Reassessment revealed that while some misarticulations persisted , the patient retained speech improvements from prior therapy , allowing for partial substitutions of target sounds . This case emphasizes the role of speech therapy in managing misarticulation despite unresolved VPI and highlights the need for ongoing multidisciplinary care.

15 August 2024 in Oral Science International
Verified
Journal Article
Closed access
TTTran Phuong Thao
Tran Phuong Thao
VNVo Truong Nhu Ngoc
Vo Truong Nhu Ngoc
LLLe Ngoc Phuong Linh
Le Ngoc Phuong Linh
ALAnh Kha Le
Anh Kha Le

24 July 2025 in Genes
Verified
Journal Article
Open access
PDF file
TTTran Phuong Thao
Tran Phuong Thao
TNTeruyuki Niimi
Teruyuki Niimi
SSSatoshi Suzuki
Satoshi Suzuki
THToko Hayakawa
Toko Hayakawa
CSChisato Sakuma
Chisato Sakuma
NNNagato Natsume
Nagato Natsume
Background/Objectives: Non-syndromic cleft lip with or without palate (NSCL/P) is a common, multifactorial congenital anomaly. As genetic associations can be population-specific, this study aimed to investigate single-nucleotide polymorphisms (SNPs) in the VAX1, MAFB, and WNT3 genes for association with NSCL/P in a Japanese cohort. Methods: A case–control study was conducted with 310 Japanese patients with NSCL/P and 308 ethnically matched healthy controls from Aichi Gakuin Dental Hospital. We genotyped SNPs rs7078160 (VAX1), rs13041247 (MAFB), and rs3809857 (WNT3) using TaqMan assays. Associations were assessed using chi-squared tests, with results stratified by sex and corrected for multiple comparisons using the Bonferroni method. Results: The VAX1 rs7078160 A allele was significantly associated with an increased risk for NSCL/P (OR = 1.67, p < 0.00001). The association was particularly strong in females (OR = 1.93, p < 0.00001) but not significant in males after correction. The MAFB rs13041247 variant showed a nominal protective association with the NSCLO subtype that was not significant after Bonferroni correction. No significant association was found for WNT3. A notable gene–gene interaction was observed, where carrying risk alleles for both VAX1 and MAFB significantly increased overall NSCL/P risk (OR = 2.65, p = 0.00008). Conclusions: VAX1 rs7078160 is a significant risk factor for NSCL/P in the Japanese population, with a pronounced female-specific effect. A synergistic interaction between VAX1 and MAFB elevates disease risk, whereas WNT3 was not implicated in this cohort. These findings underscore the population-specific genetic architecture of NSCL/P.

12 March 2025 in Cureus
Verified
Journal Article
Open access
PDF file
THTran Thi My Hanh
Tran Thi My Hanh
NHNguyen Duy Hieu
Nguyen Duy Hieu
VNVo Truong Nhu Ngoc
Vo Truong Nhu Ngoc
LALe Kha Anh
Le Kha Anh
TTTran Phuong Thao
Tran Phuong Thao
DNDao Thi Hang Nga
Dao Thi Hang Nga
Chlorhexidine digluconate (CHX) is widely recognized for its antimicrobial properties and potential use as an irrigant in endodontic treatment. However, its specific role in the treatment of primary teeth remains uncertain. This review aimed to evaluate the effectiveness of CHX in cleaning the root canal system in pediatric endodontic treatment. A total of 46 studies were initially identified from three databases: PubMed (5), ScienceDirect (2), and Cochrane (0). Following selection based on PRISMA-ScR 2018 guidelines, seven studies met all inclusion criteria and were included in the qualitative analysis. The findings indicate that CHX 2% demonstrates good antibacterial efficacy but lacks the ability to dissolve inorganic tissue. Additionally, its safety and effectiveness in dissolving organic tissue in primary teeth have yet to be thoroughly investigated. The minimum irrigation volume when using CHX is 2 ml per root canal, which ensures optimal effectiveness in bacterial elimination and improves treatment outcomes. While CHX shows promise as an endodontic irrigation solution for primary teeth, further research is necessary to fully understand its potential benefits and limitations.

7 January 2026 in Congenital Anomalies
Verified
Journal Article
Closed access
LALe Kha Anh
Le Kha Anh
TTTran Phuong Thao
Tran Phuong Thao
TNTeruyuki Niimi
Teruyuki Niimi
SSSatoshi Suzuki
Satoshi Suzuki
THToko Hayakawa
Toko Hayakawa
NNNagato Natsume
Nagato Natsume

1 January 2026 in Congenital Anomalies
Verified
Journal Article
Closed access
PDF file
TTTran Phuong Thao
Tran Phuong Thao
TNTeruyuki Niimi
Teruyuki Niimi
LALe Kha Anh
Le Kha Anh
SSSatoshi Suzuki
Satoshi Suzuki
THToko Hayakawa
Toko Hayakawa
NNNagato Natsume
Nagato Natsume